• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
NEPH

NEPH

Nephros, Inc.

NASDAQHealthcareMedical - Instruments & SuppliesUS

USD3.64

-0.16 (-4.21%)

Rating:B

Company Profile

CEO

Robert Banks

IPO Date

2004-09-21

Sector

Healthcare

Industry

Medical - Instruments & Supplies

Exchange

NASDAQ

Country

US

Market Metrics

Open

$3.75

Prev. Close

$3.80

Day Low

$3.59

Day High

$3.81

52W Low

$2.66

52W High

$6.42

Market Cap

$0.04B

Volume

0.01M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

38.4%

Avg Negative

2.4%

Avg Neutral

59.3%

News Feed

Will Nephros Inc. (NEPH) Report Negative Q2 Earnings? What You Should Know

Zacks Investment Research·7/28/2021·↑ positive

Nephros Announces Acquisition of GenArraytion, Inc.

GlobeNewsWire·7/12/2021·↑ positive

Nephros CEO Presenting at Access to Giving Virtual Investor Conference

GlobeNewsWire·7/9/2021·↑ positive

Nephros Announces Preliminary Results for Second Quarter of 2021

GlobeNewsWire·7/8/2021·↑ positive

Here's What Could Help Nephros Inc. (NEPH) Maintain Its Recent Price Strength

Zacks Investment Research·6/29/2021·↑ positive

What Makes Nephros Inc. (NEPH) a Good Fit for "Trend Investing"

Zacks Investment Research·5/31/2021·↑ positive

Nephros: Huge Growth In A Tiny Stock

Seeking Alpha·5/17/2021·↑ positive

Nephros, Inc. (NEPH) CEO Andy Astor on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/9/2021·↓ negative

Nephros Inc. (NEPH) Reports Q1 Loss, Tops Revenue Estimates

Zacks Investment Research·5/6/2021·↑ positive

Nephros Announces First Quarter 2021 Financial Results Conference Call

GlobeNewsWire·4/26/2021·↑ positive